Chiasma Inc (CHMA.OQ)
CHMA.OQ on NASDAQ Stock Exchange Global Select Market
5.94USD
18 Apr 2019
5.94USD
18 Apr 2019
Change (% chg)
$0.10 (+1.71%)
$0.10 (+1.71%)
Prev Close
$5.84
$5.84
Open
$5.81
$5.81
Day's High
$5.95
$5.95
Day's Low
$5.78
$5.78
Volume
29,494
29,494
Avg. Vol
31,434
31,434
52-wk High
$7.15
$7.15
52-wk Low
$1.20
$1.20
About
Chiasma, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial... (more)
Overall
| Beta: | 1.51 |
| Market Cap(Mil.): | $182.79 |
| Shares Outstanding(Mil.): | 30.77 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CHMA.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 62.06 | 62.40 |
| EPS (TTM): | -1.28 | -- | -- |
| ROI: | -63.95 | 12.17 | 11.78 |
| ROE: | -64.72 | 13.11 | 12.61 |
Estimates